MAPT and Alzheimer disease: In the same mouse model of early-onset AD, metformin promoted the phagocytosis of pathological amyloid-β (Aβ) and tau proteins by microglia via the enhancement of the autophagic pathway, thus reducing the abundance of Aβ deposits and severity of neuritic plaque (NP) tau-pathology [50].